Providence Wealth Advisors’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-5,000
| Closed | -$65.5K | – | 81 |
|
|
2024
Q1 | $65.5K | Buy |
5,000
+4,330
| +646% | +$56.7K | 0.06% | 78 |
|
|
2023
Q4 | $619K | Sell |
670
-2,080
| -76% | -$1.92M | 0.56% | 53 |
|
|
2023
Q3 | $29K | Hold |
2,750
| – | – | 0.03% | 69 |
|
|
2023
Q2 | $38K | Buy |
2,750
+150
| +6% | +$2.07K | 0.04% | 69 |
|
|
2023
Q1 | $31.2K | Hold |
2,600
| – | – | 0.02% | 94 |
|
|
2022
Q4 | $32.2K | Buy |
2,600
+100
| +4% | +$1.24K | 0.02% | 94 |
|
|
2022
Q3 | $18K | Hold |
2,500
| – | – | 0.01% | 96 |
|
|
2022
Q2 | $32K | Buy |
2,500
+150
| +6% | +$1.92K | 0.02% | 97 |
|
|
2022
Q1 | $75K | Hold |
2,350
| – | – | 0.05% | 98 |
|
|
2021
Q4 | $57K | Hold |
2,350
| – | – | 0.04% | 98 |
|
|
2021
Q3 | $83K | Hold |
2,350
| – | – | 0.06% | 94 |
|
|
2021
Q2 | $104K | Hold |
2,350
| – | – | 0.07% | 95 |
|
|
2021
Q1 | $80K | Buy |
2,350
+200
| +9% | +$6.81K | 0.06% | 93 |
|
|
2020
Q4 | $78K | Buy |
2,150
+150
| +8% | +$5.44K | 0.06% | 92 |
|
|
2020
Q3 | $48K | Buy |
2,000
+450
| +29% | +$10.8K | 0.05% | 85 |
|
|
2020
Q2 | $28K | Buy |
1,550
+225
| +17% | +$4.07K | 0.03% | 87 |
|
|
2020
Q1 | $20K | Buy |
1,325
+100
| +8% | +$1.51K | 0.02% | 85 |
|
|
2019
Q4 | $26K | Buy |
+1,225
| New | +$26K | 0.02% | 85 |
|